Introduction
Health and 5 Laboratory of Human Carcinogenesis, Division of Basic Science, National Cancer Institute, Bethesda, MD 20892, USA Pathogenesis of human primary hepatocellular carcinoma 6 To whom correspondence should be addressed at: Nestlé Research Centre, (HCC*), tumors that occur at high frequencies in specific Vers Chez Les Blanc, 1000 Lausanne 26, Switzerland regions of the world (e.g. Qidong, China, Mozambique, Senegal Epidemiological evidence has been supporting a relationand Mexique) has recently aroused a great deal of interest. ship between dietary aflatoxin B 1 (AFB 1 ) exposure, developGeographical variations in HCC incidence have been found to ment of human primary hepatocellular carcinoma (HCC) correlate with differences in exposure to several potential and mutations in the p53 tumor suppressor gene. However, etiological agents including hepatitis B virus (HBV), chemical the correlation between the observed p53 mutations, the carcinogens such as the dietary mycotoxin and alcoholic AFB 1 
DNA adducts and their activation pathways has not cirrhosis (1-3). Chronic infection with HBV and dietary been elucidated. Development of relevant cellular in vitro
exposure to aflatoxin B 1 (AFB 1 ) are synergistic risk factors (4) . models, taking into account species and tissue specificity, A recent prospective study has revealed, for HCC individuals could significantly contribute to the knowledge of cytopositive for HBV surface antigen, a relative risk (RR) of 7 toxicity and genotoxicity mechanisms of chemical prowhich is multiplied by a factor 8 for individuals with both carcinogens, such as AFB 1 , in humans. For this purpose a urinary aflatoxins and HBV positivity (5) . Interest in AFB 1 as non-tumorigenic SV40-immortalized human liver epithelial a risk factor for HCC has also been raised from epidemiological cell line (THLE cells) which retained most of the phase II studies which showed a positive association between AFB 1 enzymes, but had markedly reduced phase I activities was intake and a hot-spot guanine to thymine transversion mutation used for stable expression of the human CYP1A2, CYP2A6, at the third base in the codon 249 of the p53 tumor suppressor CYP2B6 and CYP3A4 cDNA. The four genetically gene (6,7, reviewed in 8) . The presence of elevated levels of engineered cell lines (T5-1A2, T5-2A6, T5-2B6 and T5-this specific mutation in nontumorous liver specimens from 3A4) produced high levels of the specific CYP450 proteins AFB 1 -exposed populations indicates that the mutagenic event and showed comparable or higher catalytic activities occurs early in the HCC pathogenesis (9) . related to the CYP450 expression when compared to human Some in vitro studies have provided indirect evidence for a hepatocytes. The T5-1A2, T5-2A6, T5-2B6 and T5-3A4 cell putative role of aflatoxin exposure in p53 mutagenesis by lines exhibited a very high sensitivity to the cytotoxic effects showing that AFB 1 causes primarily GϪT transversions in of AFB 1 and were approximately 125-, 2-, 2-and 15-fold, bacteria (10) or human cells (11, 12) . Nevertheless, these respectively, more sensitive than the control T5-neo cells, studies used shuttle vectors carrying bacterial sequences or the transfected with an expressing vector which does not human hypoxanthine guanine phosphoribosyltransferase locus contain CYP450 cDNA. In the CYP450-expressing cells, as target genes, which did not take into account the sequence nanomolar doses of AFB 1 -induced DNA adduct formation specificity and local DNA sequence effects. It has been including AFB 1 -N 7 -guanine, -pyrimidyl and -diol adducts.
previously shown that activated AFB 1 can bind the codon 249 In addition, the T5-1A2 cells showed AFM 1 -DNA adducts.
of the p53 gene (13) and preferentially induces, in a human At similar levels of total DNA adducts, both the T5-1A2 hepatoma cell line, the same GϪT transversion in the third and T5-3A4 cells showed, at codon 249 of the p53 gene, position of codon 249 of p53 as found in HCC from high AGG to AGT transversions at a relative frequency of aflatoxin regions of the world (14) . This study, however, used 15ϫ10 Ϫ6 . In contrast, only the T5-3A4 cells showed CCC S9 fraction from rat liver as AFB 1 activating system which to ACC transversion at codon 250 at a high frequency, did not reflect the human metabolic competence. whereas the second most frequent mutations found in the Bioactivation of aflatoxins has been demonstrated as a T5-1A2 cells were C to T transitions at the first and second necessary step for cytotoxic and genotoxic effects. Cytochrome P450s (CYP450s) are the principal enzymes involved in the 
Materials and methods
tumor suppressor p53 gene was done according to the restriction length polymorphism/polymerase chain reaction (RFLP/PCR) (30). This sensitive Cells and culture conditions method measures mutations on DNA sequences harboring an endonuclease The THLE (THLE-5B cl5) cells, obtained by infection of primary adult restriction site that renders this site resistant to cleavage by the specific normal human hepatocytes with the immortalizing recombinant SV40-T enzyme. The absolute mutation frequencies were calculated by calibration antigen virus, were cultured on fibronectin/collagen coated flasks in serum with mutant standards as previously described (14) . free medium LCM (23, 24) .
Isolation and primary culture of human hepatocytes were performed as previously described (25). constructs, as described in Materials and Methods.
Results

Reagents
SV40-immortalized human liver cell line
Likewise, control cells (designated T5-neo) were obtained after lipofection with the plasmid pCMVneo which does not contain CYP450 cDNA.
Western blot analysis Catalytic activities
Several clones issued from each recombinant cell line were were detected in the corresponding selected CYP450-The assay was quantitated by using known concentrations of umbelliferone.
expressing THLE cells, whereas no CYP450 expression could About 6ϫ10 3 cells/cm 2 surface area seeded in 24-well plates were exposed to various concentrations of AFB 1 . After 24 h, the cells were washed once in
P450 catalytic activities
Hanks' buffered saline solution and fresh medium was added. After 24 h, CYP450 expression was further assessed by measuring lysosomal hexosaminidase activity was measured as described (28) except that the p-nitrophenol-N-acetyl-β-D-glucosamide substrate was dissolved in specific catalytic activities in whole cells (Table I ). The The cells were exposed to the indicated concentrations of AFB 1 for 24 h extracts from CYP450-expressing THLE cells: T5-1A2 (A), T5-2A6 (B), before washing and addition of fresh medium. Cytotoxicity, measured after T5-2B6 (C), T5-3A4 cells (D). The panels A, B, C and D correspond to the additional 24 h, is expressed as survival to the corresponding untreated blots developed by using rabbit antibodies anti-rat Cyp1A, Cyp2A3, cells. The CD50 value corresponds to the dose of AFB 1 needed to obtain Cyp2B1 and anti human CYP3A, respectively, as described in Materials and 50% of toxicity. r, T5-neo; j, T5-1A2; u, T5-3A4; d, T5-2A6; s, T5-methods.
2B6 cells.
concentration-dependent decrease in relative survival was (Figure 2 ). On the CD50 basis, the T5-1A2, the T5-3A4 and both T5- whether activation of AFB 1 by the different CYP450-expressing cell lines and subsequent formation of DNA adducts EROD and MROD activities in the T5-1A2 cells were induced mutations in the codon 249 and 250 of the p53 tumor 29 Ϯ 6 and 41 Ϯ 5 pmol/min/mg total protein, respectively. suppressor gene. The T5-1A2, T5-2A6 and T5-3A4 cells were The T5-2A6, T5-2B6 and T5-3A4 cells showed a high level treated with different concentrations of AFB 1 and the total of CH activity (869 Ϯ 100 pmol/min/mg protein), BROD DNA adduct formation was measured in each cell line (data activity (58 Ϯ 4 pmol/min/mg protein) and 6β-TH activity not shown). At the linear range, the T5-1A2 cells showed (260 Ϯ 91 pmol/min/mg protein), respectively. Only low level approximately a 3-and 10-fold higher efficiency in the of MROD activity (0.42 Ϯ 0.12 pmol/min/mg total protein) activation of AFB 1 to genotoxic intermediates than the T5-could be detected in the control T5-neo cells, which correlated 3A4 and T5-2A6 cells, respectively. For the analysis of adduct with the low level of CYP1A2 protein expression observed in species and p53 mutations, conditions were used to obtain the parental cell line (Figure 1) (24) . The T5-1A2, T5-2A6, similar levels of total DNA adducts in the three cell lines. T5-2B6 and T5-3A4 cells showed 7-, 4-, 30-and 1.5-fold Indeed, by treating the T5-1A2, T5-3A4 and T-2A6 cells with higher level of the corresponding catalytic activities than 24, 80 and 240 nM AFB 1 , we have observed the formation of 24-h cultured human hepatocytes (Table I) . After 1 day in 1.5 Ϯ 0.3, 2.2 Ϯ 0.7 and 0.98 Ϯ 0.1 pmol tritiated metabolites/ culture, a 65% loss of CYP450 activity was observed in human mg DNA, respectively. Parallel evaluation of the AFB 1 cytohepatocytes (M.Gomez-Lechon, personal communication).
toxic effects showed 20, 25 and 45% of viability for the T5-Therefore, these data indicate that the T5-1A2, T5-2A6 and 1A2, T5-3A4 and T5-2A6 cell lines, respectively, as determined T5-3A4 cell lines showed nearly liver-like expression of by DNA content measurement between the treated and CYP450, whereas the T5-2B6 expressed 20-fold higher level untreated cells. of BROD activity than fresh hepatocytes.
Analysis of hydrolysed DNA isolated from the AFB 1 -treated AFB 1 -induced cytotoxicity cells by reverse-phase liquid chromatography showed the presence of the following adducts in the three cell lines: (1) The cytotoxicity effects of AFB 1 in the different T5-CYP450 cells and in the T5-neo control cells were examined. A The 8,9-dihydro-8-(N 7 -guanyl)-9-hydroxyaflatoxin B 1 (AFB- N 7 -Gua) adduct resulting from the interaction between AFB 1 -8,9-epoxide and the 7-position of guanine, (2) the ring-opened formamidopyrimidine (AFB 1 -Fapyr) derivatives (major and minor forms) issue from non-enzymatic conversion of the N 7 -guanyl adduct (32) and (3) AFB-8,9-dihydrodiol (AFBdiol), an additional decomposition product of the initial N 7 -guanyl adduct. In the three cell lines, the AFB-Fapyr adducts represented Ͼ50% of the total DNA adduct formation (Table II) . Surprisingly, high levels of AFM 1 adducts (15% of total adducts) could be detected in the T5-1A2 cells, but not in the other CYP450-expressing cell lines.
AFB 1 -induced p53 mutations
Subsequent analysis of p53 mutations at codons 249 and 250 were performed in the T5-1A2, T5-2A6 and T5-3A4 cells, and absolute mutation frequencies were calculated as previously described (14) . As shown in Figure 3 , different mutational spectra were observed in the T5-1A2 and T5-3A4 cell lines, whereas no significant AFB 1 -induced p53 mutations could be detected in the T5-2AB cells. The major mutations found in the T5-3A4 cells were AGG→AGT and CCC→ACC transversions at codons 249 and 250, respectively, with a frequency of~15ϫ10 Ϫ6 ( Figure 3A ). Additional mutations including AGG→AGA transition, AGG→ATG transversion at codon 249 and CCC→CAC transversion at codon 250 could be detected in this cell line with a frequency of~5ϫ10 Ϫ6 ( Figure 3A and B) . The T5-1A2 cells showed a similar frequency of AGG→AGT transversion at codon 249 as observed in the T5-3A4 cells. In T5-1A2 cells, the major mutations were C to T transitions at the first and second position of the codon 250, at a frequency of about~20ϫ10 Ϫ6 . Figure 3A ).
residues in brackets are not part of the restriction site and were not analysed.
Discussion
We report here the development of four human liver epithelial cytes showed that T5-1A2, T5-2A6 and T5-3A4 cells displayed CYP450 liver-like expression. cell lines (THLE cells) stably expressing CYP1A2, CYP2A6, CYP2B6 and CYP3A4 cDNA, and showing the ability to The CYP2A6 and CYP2B6 are considered the less active isoforms in human liver, but a controversy exists between activate AFB 1 to cytotoxic and genotoxic intermediates. Whereas the high interindividual variability in phase I expres-CYP1A2 and CYP3A4 regarding their predominance for AFB 1 activation. Evaluation of the AFB 1 cytotoxicity effects in each sion in humans complicates the establishment of cellular models with CYP450-liver like expression, direct comparison CYP450-expressing THLE cell line indicated that the T5-1A2 cells were 8-and 60-fold more sensitive than the T5-3A4, and of the ethoxyresorufin, methoxyresorufin O-deethylase, coumarin and testosterone hydroxylase activities with human hepatoboth T5-2A6 and T5-2B6 cells, respectively. Quantitative
Western blots of microsomal standards (Gentest Corp., Woburn, through hydroxylation reactions (41) and DNA adducts of AFM 1 epoxides constitute~5% of the total AFB 1 -induced MA) containing known amount of CYP450 allowed estimation of the level of expression of CYP1A2, CYP2A6 and CYP3A4 DNA adduct formation in rat liver (42) . However, these adducts have never been adequately examined in human liver samples. in the THLE cells to be 106, 62 and 25 pmol/mg of microsomal protein, respectively (data not shown). Therefore, when the The T5-1A2 cells showed~4-fold higher level of catalytic activity than the average activation level of 10 samples of T5-1A2, T5-2A6 and T5-3A4 cells were compared for their ability to activate AFB 1 to cytotoxic products, the cells fresh human hepatocytes, but marked variability (Ͼ50%) in levels of CYP1A2 protein has been seen in human liver containing CYP1A2 were 2-and 30-fold more sensitive to AFB 1 than cells expressing CYP3A4 and CYP2A6, respectspecimens (20,43). Therefore, this result cannot be explained by over-expression of CYP1A2 in the cell line. On the other ively. Similar results were obtained by Crespi et al. (17) using CYP450-expressing human lymphoblastoid cell lines.
hand, specific DNA repair enzymes responsible for the catalytic removal of AFM-adducts could be absent in the cell lines. In order to clarify the role of each CYP450 in the induction of mutations in the p53 gene, which is frequently mutated during
Additional metabolites, such as AFQ 1 and AFP 1 are formed during biotransformation of AFB 1 by CYP450s. Whereas hepatocarcinogenesis, two criteria were taken into account. Normalization of the AFB 1 treatments could be based on the AFQ 1 seems to be a poor substrate for epoxidation and subsequent DNA binding, AFP 1 -adducts were found in the same cytotoxic effects or on the same DNA-adduct levels. As the cytotoxic effects are more related to protein adduct formaliver of rats exposed to AFB 1 (42), but was not described in human liver. Interestingly, none of these adducts were found tion we chose to evaluate the AFB 1 -induced mutagenicity in the different cell lines on the basis of total DNA adduct in the T5-1A2, T5-2A6 and T5-3A4 cell lines, indicating that AFB 1 and AFQ 1 are not relevant human metabolic products formation. Indeed, when the T5-1A2, T5-3A4 and T5-2A6 cells were treated with 24, 80 and 240 nM AFB 1 , respectively, of AFB 1 . In this study we have shown that the formation of AFB 1 -we obtained 1.5 Ϯ 0.3, 2.2 Ϯ 0.7 and 0.96 Ϯ 0.1 pmol adducts/mg DNA, which are about the levels of DNA adducts DNA adducts induced an increase in the levels of p53 mutations in the T5-1A2 and T5-3A4 cell lines, but not in the T5-2A6 found in human liver of AFB 1 -exposed individuals;~3.5 pmol adducts/mg DNA have been found in normal or tumour human cells. This discrepancy could be due to the~2-fold lower levels of DNA adducts found in the T5-2A6 cells (0.98 pmol liver tissues (33,34). In our experimental conditions, 80, 75 and only 55% of cytotoxicity were observed in the T5-1A2, adducts/mg DNA) compared to the T5-1A2 and T5-3A4 cells (1.5 Ϯ 0.3 and 2.2 Ϯ 0.7 adducts/mg DNA, respectively), the T5-3A4 and T5-2A6 cell lines, respectively, indicating no obvious relationship between cytotoxicic effects and DNA latter leading to a saturation of the enzyme repair system. Another explanation could be a different DNA repair capacity adduct formation. When the total adducts obtained in each cell line were related to the AFB 1 doses and the level of CYP450 displayed by the three CYP450-expressing cell lines, although they stemming from the same parental cell line. However, the contents we observed that the T5-3A4 cells were 2-and 16-fold more efficient in the activation of AFB 1 than the T5-same levels of UVB-induced cytotoxicity (CD50 of 2.25 kJ/ m 2 ) were observed in the three cell lines indicating equivalent CYP1A2 cells and the T5-CMV2A6 cells, respectively. These results suggest that CYP1A2 is more efficient in the activation efficiency of the DNA excision repair enzymes (data not shown). of AFB 1 to cytotoxic products and CYP3A4 for genotoxic metabolite formation. This observation might be explained by
The contribution of each DNA adduct to the induction of mutation is not clearly shown. The Fapyr derivates are relatively the fact that certain metabolites such as AFB 2α , produced at different levels by the CYP450s, are more likely to be involved persistent in vivo and suspected to be responsible for the induction of mutations during DNA replication (32). By using in the protein binding and subsequent acute cytotoxicity than in DNA adduct formation and genotoxic effects (35, 36) .
an oligonucleotide containing a single AFB 1 -N 7 -Gua adduct, Bailey et al. (44) have recently shown that the aflatoxin moiety AFB 1 treatment of the T5-1A2, T5-2A6 and T5-3A4 cells induced DNA adducts, including AFB 1 -N 7 -Gua, AFB-Fapyr of the adduct is involved in the G→T and, to a lesser extent, G→A mutations at the site of the lesion. Although both forms and, to a lesser extent, AFB-diol, which occurs in vitro (29) and in vivo (37,38). In the T5-1A2 cells, only 8% of the qualitative and small quantitative differences of DNA adducts were found, the T5-1A2 and T5-3A4 cells displayed common total identified adducts were found to be AFB 1 -N 7 -Gua adduct [trans-2,3-dihydro-2-(N 7 -guanyl)-3-hydroxy AFB 1 ], whereas AFB 1 -induced mutations, including the G→T transversion at the second and the third position of the codon 249, the latter it represented 18% in both T5-3A4 and T5-2A6 cell lines. AFB 1 -Fapyr major [2,3-dihydro-2-(N 5 -formyl-2,3,6-triaminobeing linked to the serine 249 mutant p53 protein, preferentially found in HCC from high AFB 1 regions of the world (8). 4-oxopyrimidine-N 5 -yl)-3-hydroxy AFB 1 ] and minor [8,9-dihydro-8-(2-amino-6-formamide-4-oxo-3,4-dihydropyrimidNumerous mutations at the cytosine sites were also detected. Among them, very high levels of C→T transitions at codon 5-yl formamido)-9-hydroxy AFB 1 ] forms, issue from the spontaneous, non-enzymatic stabilisation of AFB 1 -N 7 -Gua by 250 were found exclusively in the T5-1A2 cells suggesting that the AFM-adduct is involved in the induction of these the opening of the imidazole ring (39), represented around 70% of the total adducts in the three cell lines. Although the mutations. The C→A transversion at the first position of codon 250, which corresponds to a G→T transversion on the dihydrodiol form of AFB 1 is more related to protein-adduct formation it has been shown to react with nucleic acids in vitro transcribed DNA strand, was the second major mutation found in HepG2 cells treated with AFB 1 activated by rat liver and in vivo (37, 40) . This adduct comprised 6, 8 and 11% of the DNA adducts that are present in the T5-1A2, T5-3A4 and microsomes (14) . Interestingly, a similar pattern of transversions at codons 249 and 250 was obtained in these two T5-2A6 cells, respectively. Surprisingly, high levels of AFM 1 -adducts (20% of the total adducts) were found in the AFB 1 -cellular models. However, the CYP450-expressing THLE cells displayed a 10-100-fold higher mutation frequency than the treated T5-1A2 cells. Several studies have previously shown that CYP1A2 catalyses the conversion of AFB 1 to cellular growth advantage and induction of tumorigenicity.
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharm-
